Meta-Manus Review: Key Compliance Risks for Enterprise AI Buyers

Meta's $2 billion acquisition of AI agent startup Manus has become a cautionary tale for enterprise CTOs on cross-border compliance risks. China's Ministry of Commerce announced on January 9th that it would review whether the deal violated export controls, technology transfer rules, and overseas investment regulations, despite Manus relocating from Beijing to Singapore in 2025.

The investigation reveals an uncomfortable truth for enterprise AI buyers: a vendor's corporate headquarters does not define its regulatory exposure.

"The AI agent technology developed by Manus is precisely the type that could fall under Chinese export controls," said Dai Menghao, a Shanghai-based partner at King & Wood Mallesons specializing in export controls and sanctions, in an interview with the South China Morning Post. The nature of the technology itself, not the company's registration, determines the applicable jurisdiction.

When relocation doesn’t equal regulatory freedom

Manus seemed to have done everything right to achieve regulatory independence. The company moved its 105-person team from Beijing to Singapore in the summer of 2025, laid off 80 mainland China-based employees, established operations in Singapore, Tokyo, and San Francisco, and secured $75 million in funding from US firm Benchmark.

Meta stated in December that "there will be no continuing Chinese ownership interests in Manus AI following the transaction, and Manus AI will discontinue its services and operations in China."

However, Ministry of Commerce spokesperson He Yadong made it clear that corporate structure alone does not guarantee compliance. "The Chinese government consistently supports enterprises in conducting lawful, mutually beneficial transnational operations and international technological cooperation," he said at a January 9th press briefing.

"But it must be emphasized that external investment, technology exports, data exports, and cross-border acquisitions by companies must comply with Chinese laws and regulations and undergo the necessary approval processes."

The investigation will scrutinize when, how, and which specific technologies Manus transferred abroad from its China-based entities, according to Cui Fan, a professor at the University of International Business and Economics and chief expert at the China Society for World Trade Organization Studies.

If regulators determine that Manus should have obtained export licenses before transferring technology or talent, the company's founders could face criminal charges under Chinese law.

The regulatory framework that enterprise buyers must understand

China updated its technology export control regulations in 2020, expanding their scope to include certain algorithms—a move widely seen as strengthening Beijing's legal authority to intervene in deals involving strategic technologies.

These updates gained significant attention after the US pressured ByteDance to divest TikTok's American operations, prompting China to assert its oversight over outbound technology transfers. The framework covers three critical areas that enterprise AI buyers must consider when evaluating vendor risk:

Export controls: Advanced AI agents, models, and related intellectual property are classified as strategic assets subject to licensing requirements. Beijing maintains jurisdiction over technology developed within China, regardless of where the developing company later incorporates.

Data security rules: Cross-border transfers of data, particularly datasets used to train or fine-tune AI models, require regulatory approval. The location where the data processing or training occurred is more significant than where the AI model is ultimately deployed.

Overseas investment regulations: When Chinese nationals transfer technology assets abroad, even through legitimate corporate restructuring, authorities assess whether the transfer requires prior government clearance.

Wang Yiming, a partner at the Beijing Xinzheng law firm, estimates the Manus review could take up to six months, aligning with timelines for similar technology transfer assessments. "This could become a high-profile test case for China's equivalent of the US Committee on Foreign Investment," Winston Ma, an adjunct professor at New York University School of Law focusing on AI and the digital economy, told the SCMP.

What this means for AI vendor due diligence

The Manus case highlights gaps in how enterprise buyers assess AI vendor regulatory risk. Standard procurement processes typically focus on data residency, service level agreements, and contractual liability.

Few companies evaluate whether a vendor's technology development history creates ongoing compliance exposure across multiple jurisdictions.

Enterprise buyers should now ask AI service providers the following:

Technology origin questions:

• Where was the core AI model or agent technology originally developed?
• Which jurisdictions' export control regimes might claim authority over this technology?
• Were any team members involved in the development process Chinese nationals?

Transfer compliance:

• If the company has relocated, what specific regulatory approvals were obtained for the technology transfer?
• Can the vendor demonstrate compliance with export license requirements for all past technology transfers?
• What contingency plans exist if regulators challenge previous transfers?

Operational continuity:

• How would a regulatory investigation impact ongoing service delivery and support?
• What are the vendor's obligations to notify customers during regulatory review periods?
• Does the vendor maintain insurance or financial reserves to cover potential regulatory risks?

"The most likely outcome I see is a lengthier approval process with potential conditions on how Manus's China-developed technology can be used, rather than an outright block," Nick Patience, AI lead at The Futurum Group, told CNBC. "But the threat of stricter action gives Beijing significant bargaining power in this high-profile, US-led acquisition."

The precedent risk for enterprise AI strategy

This investigation has implications far beyond Meta's specific deal. If Beijing determines it can assert jurisdiction over AI technology of Chinese origin regardless of subsequent corporate restructuring, it sets a precedent for ongoing regulatory reach into global enterprise AI supply chains.

Enterprise buyers using AI agents for market research, coding assistance, or data analysis—precisely the services Manus offered before its acquisition—must now consider questions about provider stability during geopolitical disputes. The company achieved $100 million in annual recurring revenue within eight months of launch, demonstrating both rapid enterprise adoption and how quickly mission-critical dependencies can form.

Winston Ma noted that a smooth approval could "create a new pathway for young AI startups in China"—combining physical relocation with foreign acquisition to navigate technology transfer restrictions.

Conversely, regulatory intervention signals that Beijing will pursue oversight of Chinese-origin AI companies even after they relocate, potentially closing what seemed to be an escape route for startups navigating US-China tensions.

For enterprise AI buyers, the lesson is clear: compliance risk extends beyond a vendor's contractual terms into complex jurisdictional questions about where and by whom the core technology was originally developed. This is a due diligence requirement most procurement teams are not yet equipped to handle.

See also: Manus AI agent: breakthrough in China’s agentic AI

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. This comprehensive event is part of TechEx and co-located with other leading technology events. Click here for more information.

AI News is powered by TechForge Media. Explore other upcoming enterprise technology events and webinars here.